Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

Back to Top

New Debate Series on 14 Nov! Register Now!


Last chance to register for our next Debate Series...

"Alzheimer's Disease, New Perspectives and Horizons"

Tuesday November 14th, 2023 at 7:00 AM CDT/IPA Secretariat

Click here to register now!

(See this event in your local time)

The International Psychogeriatric Association (IPA) presents a new Debate Series"Alzheimer's Disease, New Perspectives and Horizons."

We are joined by Myrra Vernooij-Dassen, Paola Barbarino, & Jeff Cummings as our speakers on who will explore different approaches to this devastating disease.

Our speakers will be debating different and complementary perspectives regarding how to face Alzheimer's Disease and present and future strategies and tools in Alzheimer´s Disease.

Registration is now open and we hope you will join us!

  -IPA Debate Series Task Force

Speaker Information:


Prof. Myrra Vernooij-Dassen (the Netherlands)

Professor Myrra Vernooij-Dassen has been trained as a medical sociologist. She is former director of Radboud Alzheimer Center and emeritus professor in psychosocial aspects of care for frail elderly people. She is a member of the Scientific Advisory Board of the European Joint Programme Neurodegenerative Diseases (JPND) and Chair of the IPA Webinar Series. She has a special interest in social health in relation to dementia.

    Carlos De Menconca Lima.png

Paola Barbarino (United Kingdom)

Paola Barbarino is CEO of Alzheimer’s Disease International. Prior to this, she was CEO of LIFE and occupied senior positions with Cass Business School, Tate, British Library and IIED. She is a Board Member of the World Dementia Council, a Trustee of The Postal Museum and of Lauderdale House. Previously she was a Non-Executive Director of the Non-Communicable Disease Alliance (NCDA), a Trustee of Shelter, the housing/homelessness charity, and of MLA London. She holds a degree cum laude in Classics from Federico II Napoli University, an MA in Field and Analytical Techniques in Archaeology and an MA in Library and Information Science both from University College London.

Dr. Jeff Cummings (United States)

Dr. Cummings is the Director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada Las Vegas (UNLV). He is a neurologist and a clinical trialist who led many clinical trials and drug development programs. He has had neurological leadership positions at the University of California Los Angeles (UCLA), the Cleveland Clinic, and UNLV. His research embraces studying the Alzheimer’s drug development pipeline and the influence of biomarkers on drug development.

Moderator: Edgardo Reich, MD IPA Debate Series- Program Organizer  Hospital Julo Mendez, Universidad de Buenos Aires  ARGENTINA

Moderator: Raimundo MateosMD, PhD IPA Debate Series- Program Organizer Universidad de Santiago de Compostela  SPAIN

Facebook  LinkedIn  Twitter  Instagram


Acadia Pharmaceuticals Axsome Cambridge University Press Cerevel Lundbeck Otsuka